Gyeonggi-do, South Korea

Kyu Hwan Lee

USPTO Granted Patents = 5 



Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2014 - 2020)
  • Ansan-si, KR (2018 - 2020)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kyu Hwan Lee

Introduction

Kyu Hwan Lee is a notable inventor based in Gyeonggi-do, South Korea, with a commendable total of four patents to his name. His work largely focuses on pharmaceutical compositions aimed at preventing and treating metabolic diseases. His innovative approach combines chemistry and medicine, addressing pressing health issues such as obesity and diabetes.

Latest Patents

Kyu Hwan Lee's latest innovations include two remarkable patents that highlight his expertise in the field of pharmaceutical compositions. The first patent involves a composite preparation containing a novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative. This composition is designed to combat metabolic diseases and can be mixed with other active ingredients, such as DPPIV inhibitors and sodium/glucose cotransporter 2 (SGLT2) inhibitors. The results of this invention indicate a significant reduction in blood sugar levels across various animal models suffering from diabetes-related conditions.

The second patent focuses on a cyclohexene derivative that enhances intracellular activity of cyclic adenosine monophosphate (cAMP) through the activation of G protein-coupled receptor 119 (GPR-119). This derivative offers weight loss and hypoglycemic effects by promoting the release of glucagon-like peptide-1 (GLP-1), making it a potential treatment for a range of metabolic disorders, including both types of diabetes and associated conditions.

Career Highlights

Throughout his career, Kyu Hwan Lee has worked with esteemed companies such as Hyundai Pharm Co., Ltd. and Hyundai Motor Company. His positions at these organizations have allowed him to hone his skills and apply his innovative ideas in practical settings, further demonstrating his commitment to advancing health-related technology.

Collaborations

In his professional journey, Kyu Hwan Lee has collaborated with Jin Wook Yang, enhancing his research and development potential. Such partnerships are vital in the field of innovation, as they combine expertise and foster the creation of groundbreaking solutions.

Conclusion

Kyu Hwan Lee stands out as a key figure in the realm of pharmaceutical innovations. His contributions to metabolic disease treatments through his patents reflect not only his ingenuity but also his dedication to improving healthcare outcomes. As he continues to innovate, the impact of his work is sure to be felt in the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…